Facebook Pixel

Ovarian Cancer and Why I'm A Fan of Clinical Trials

By HERWriter
 
Rate This

Clinical trials are not for everybody and are not always successful. It is, after all, a trial. But for me, entering a clinical trial when I had an aggressive recurrence of ovarian cancer, it was the right choice. Admittedly, I entered the trial with little expectation of success, but I was so wrong.

My trial drug was a monoclonal antibody drug that works by turning on the “suicide” switch, a process called apoptosis. Healthy cells know when to die, but cancer cells go awry and keep growing uncontrollably, building tumors that eventually kill the host. I was "hosting" seven new tumors (four on the liver) and standard treatments were no longer working.

I was nervous about testing a unproven drug, especially at Phase I - the first time it was tried on humans. What new thing might grow as a result? Could I end up worse than with my current problem? However, consulting with several oncologists about my options and by gaining an understanding of how monoclonal antibodies function, I entered the trial.

In all the years I’ve dealt with cancer treatments, this was the easiest experience. I was not ill during treatment, experienced virtually no side effects. I was examined more closely than I ever have been; essentially every orifice and bodily function was monitored with great interest by the researchers. Most importantly, several tumors disappeared after a few weeks, while the remainder became necrotic with no signs of life for two years.

Did it cure my cancer? No. But it bought me more time; time without painful treatments, a holiday of sorts from a long, difficult cancer journey.

Not every trial is this successful. In fact, other patients on the same drug did not have the same response, but I know that clinical trials are another weapon in the arsenal that helps me stay alive.

For more information, go to the National Institutes of Health website: www.clinicaltrials.gov.

Add a Comment6 Comments

EmpowHER Guest
Anonymous

Annette,

Thank you for an excellent and accurate response. The only time a placebo or no treatment is allowed in an oncology trial is when no standard treatment exists. Even in these studies, the patient receives what is called "best supportive care," drugs for comfort and to control disease symptoms. The National Cancer Institute website has a great website that discusses this and other issues that patients considering a clinical trial should consider. http://www.cancer.gov/clinicaltrials/learning/should-I-take-part

In the PRECEDENT Study, participants are treated either with Doxil, an FDA approved drug used to treat ovarian cancer, or with a combination of Doxil and EC145, the investigational drug.

Dave Morgenstern
Director, Clinical Affairs
Endocyte, Inc.

July 16, 2009 - 8:41am

This Comment

EmpowHER Guest
Anonymous

how do you know you won't be one of control group? you'd better believe wholeheartedly in the placebo effect. i wish i could be so credulous. persuade me please.

July 6, 2009 - 5:31am

This Comment

EmpowHER Guest
Anonymous (reply to Anonymous)

According to the National Institutes of Health, in oncology trials, there is no placebo. Patients are given treatment with standard or trial drugs, but never "untreated." Also, if the disease progresses while they are on the trial drug, they are taken out of the trial and returned to traditional treatment. Standards for oncology trials are extremely rigid. You can find more info about the clinical trial process at this site: http://www.ovariancancer.org/index.cfm?fuseaction=Page.viewPage&pageId=526
I hope this helps. If you want more info on my experience, please contact me again. Annette

July 11, 2009 - 8:15am

This Comment

EmpowHER Guest
Anonymous

That website is www.endocyte.com/precedent

June 26, 2009 - 9:04am

This Comment

EmpowHER Guest
Anonymous

Annette,

Thank you for a great article sharing your experience. Women interested in information about Endocyte's ongoing clinical trial for women with platinum-resistant ovarian cancer can go to the PRECEDENT page at Endocyte's website www.precedent.com.

Dave Morgenstern
Director, Clinical Affairs
Endocyte, Inc.

June 26, 2009 - 9:02am

This Comment

EmpowHER Guest
Anonymous

This is a great article, Annette! Thanks for sharing your story. I wanted to let you and your readers know about our clinical trials matching service: www.healogica.com. We just launched the website 2 months ago. Check it out!

Ed Shin
[email protected]

June 19, 2009 - 7:27am

This Comment

Image CAPTCHA
Enter the characters shown in the image.
By submitting this form, you agree to EmpowHER's terms of service and privacy policy
Add a Comment
Annette Leal Mattern
HERWriter View Profile Send Message

We value and respect our HERWriters' experiences, but everyone is different. Many of our writers are speaking from personal experience, and what's worked for them may not work for you. Their articles are not a substitute for medical advice, although we hope you can gain knowledge from their insight.